Let's talk medical research

Over the past year and a half, the traditional clinical research model of patient outreach, in-person screening, and site-based follow-up has had to adjust to drive progress while keeping patients safe. Now, with vaccines driving positivity rates down, we can begin to think about what’s next. Still, questions remain: Of all the changes made in the research industry since the beginning of the ...

COVID-19 took the world by storm in 2020, propelling scientists, healthcare workers, first responders, governments, and pharma companies from around the globe to band together with the goal of curbing the pandemic. As we continue to learn about COVID-19, more and more research is being published about the virus, vaccines and treatments, and the virus’ behaviors. We highlight a few recent ...

Clinical trial recruitment can be a difficult puzzle to solve. In fact, approximately 80% of clinical trials are delayed or closed because of problems with recruitment. However, with the right tools at your fingertips, finding the right patients for your studies can become a realistic goal. We share three clinical trial recruitment tools that drive success.

For patients, joining a clinical trial is a significant decision. Before signing on, it's important to consider everything from how easy it is to get to the site location to whether or not the goals of the trial resonate with you. 

Parkinson’s disease is a disorder of the central nervous system that affects movement, with symptoms such as tremor, slow movement, stiffness, and loss of balance. Current treatments come with side effects, and there is no cure. This means research is critical to developing new and better treatments for the nearly one million people in the US living with Parkinson’s disease. 

At Antidote, our mission is to connect patients with clinical research opportunities. But one phrase we hear often from patients goes something like this: "Medical research is great, but it's not for me."

It’s a big day here at Antidote! We’re thrilled to announce the close of a $23.2M funding round, led by LBO France with contributions from existing investors Merck Global Health Innovation Fund, Smedvig Capital, and Octopus Ventures. 

Thousands of research studies and clinical trials are carried out every year around the world with the hope of bringing potential treatment options and medical devices to market. However, approximately 80% of clinical trials are delayed or closed because of problems with recruitment. Clinical trials require a careful, meticulous approach to selecting participants, and finding the volunteers who ...

Patients are at the core of clinical research, and in our work, we’re lucky enough to meet advocates and amplify their voices. We were thrilled to have a conversation with Courtney Wulf, a lupus patient and the principal/founder at Premier Patient Advocacy Associates. She spoke to us about the need for a strong support system, how COVID-19 has impacted lupus patients, the connection between lupus ...

More than 16 million Americans have chronic obstructive pulmonary disease (COPD) and millions more may have it but don’t recognize the symptoms until later stages of the disease. COPD is a chronic inflammatory lung disease that causes obstructed airflow from the lungs, making it hard to breathe. Emphysema and chronic bronchitis are the two most prevalent conditions that contribute to the ...